Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,475.00 at Evercore ISI

Mettler-Toledo International (NYSE:MTD) had its price objective upped by Evercore ISI from $1,450.00 to $1,475.00 in a research note released on Monday,Benzinga reports. The firm currently has an outperform rating on the medical instruments supplier’s stock.

Other equities analysts have also recently issued research reports about the company. Robert W. Baird raised their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a report on Monday. Wolfe Research began coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating for the company. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their price target for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Stifel Nicolaus dropped their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. Finally, Wells Fargo & Company upped their target price on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $1,368.00.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,339.46 on Monday. The firm’s 50 day moving average price is $1,278.92 and its 200-day moving average price is $1,342.95. Mettler-Toledo International has a 1 year low of $1,133.46 and a 1 year high of $1,546.93. The stock has a market cap of $28.26 billion, a P/E ratio of 33.05, a PEG ratio of 4.80 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 564.51%. As a group, equities analysts expect that Mettler-Toledo International will post 41.94 EPS for the current year.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.94% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Several hedge funds and other institutional investors have recently modified their holdings of MTD. Generali Asset Management SPA SGR purchased a new position in Mettler-Toledo International during the 4th quarter valued at $1,512,000. Axxcess Wealth Management LLC increased its stake in Mettler-Toledo International by 6.7% in the 4th quarter. Axxcess Wealth Management LLC now owns 870 shares of the medical instruments supplier’s stock worth $1,065,000 after buying an additional 55 shares during the period. Cibc World Markets Corp boosted its position in Mettler-Toledo International by 13.0% in the 4th quarter. Cibc World Markets Corp now owns 3,315 shares of the medical instruments supplier’s stock valued at $4,056,000 after buying an additional 382 shares during the period. Envestnet Portfolio Solutions Inc. grew its stake in Mettler-Toledo International by 5.8% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 513 shares of the medical instruments supplier’s stock worth $628,000 after acquiring an additional 28 shares in the last quarter. Finally, Frank Rimerman Advisors LLC increased its position in shares of Mettler-Toledo International by 7.4% during the fourth quarter. Frank Rimerman Advisors LLC now owns 408 shares of the medical instruments supplier’s stock worth $499,000 after acquiring an additional 28 shares during the period. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.